Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
RESEARCH TOOLSreports
Collegium Pharmaceutical (COLL) Ownership - Who Owns Collegium Pharmaceutical?
458 Followers
Collegium Pharmaceutical (COLL) Ownership Overview
26.00% Insiders
36.46% Mutual Funds
36.44% Other Institutional Investors
1.10% Public Companies and Individual Investors
The ownership structure of Collegium Pharmaceutical (COLL) stock is a mix of institutional, retail and individual investors. Approximately 72.90% of the company’s stock is owned by Institutional Investors, 26.00% is owned by Insiders and 1.10% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 28, 2024 | Scott Dreyer Evp & Cco | xxxxxxxxxxxxx | $3662190 |
| May 16, 2024 | Garen Bohlin Director | xxxxxxxxxxxxx | $936216 |
| Mar 04, 2024 | Thomas B Smith Evp And Chief Medical Officer | xxxxxxxxxxxxx | $36576 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $86956 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $203805 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $223447 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $311142 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,002,170 | Institution | 12.23% | 129,510,221 | |
| 3,323,761 | Institution | 10.16% | 107,556,906 | |
| 2,679,093 | Institution | 8.19% | 86,695,449 | |
| 1,985,557 | Institution | 6.07% | 64,252,625 | |
| 1,477,606 | Institution | 4.52% | 47,815,330 | |
| 925,379 | Institution | 2.83% | 29,945,264 | |
| 698,950 | Institution | 2.14% | 22,618,022 | |
| 621,586 | Institution | 1.90% | 20,114,523 | |
| 546,559 | Institution | 1.67% | 17,686,649 | |
| 432,733 | Institution | 1.32% | 14,003,240 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,679,093 | Institution | 8.19% | 86,695,449 | |
| 1,477,606 | Institution | 4.52% | 47,815,330 | |
| 925,379 | Institution | 2.83% | 29,945,264 | |
| 698,950 | Institution | 2.14% | 22,618,022 | |
| 546,559 | Institution | 1.67% | 17,686,649 | |
| 432,733 | Institution | 1.32% | 14,003,240 | |
| 344,279 | Institution | 1.05% | 11,140,868 | |
| 334,499 | Institution | 1.02% | 10,824,388 | |
| 318,341 | Institution | 0.97% | 10,301,515 | |
| 316,301 | Institution | 0.97% | 10,235,500 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,318,090 | Institution | 10.14% | 106,477,508 | |
| 2,139,781 | Institution | 6.54% | 69,243,313 | |
| 992,745 | Institution | 3.03% | 31,966,389 | |
| 867,656 | Institution | 2.65% | 28,077,348 | |
| 502,750 | Institution | 1.54% | 16,188,550 | |
| 319,599 | Institution | 0.98% | 10,342,224 | |
| 292,275 | Institution | 0.89% | 9,458,019 | |
| 284,064 | Institution | 0.87% | 9,115,614 | |
| 194,346 | Institution | 0.59% | 6,289,037 | |
| 175,169 | Institution | 0.54% | 5,621,173 |
FAQ
Who Owns Collegium Pharmaceutical (COLL)?
According to the latest TipRanks data, approximately 36.44% of the company's stock is held by institutional investors, 26.00% is held by insiders, and 1.10% is held by retail investors.
What percentage of Collegium Pharmaceutical (COLL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.44% of Collegium Pharmaceutical (COLL) stock is held by institutional investors.
What percentage of Collegium Pharmaceutical (COLL) stock is held by retail investors?
According to the latest TipRanks data, approximately 1.10% of Collegium Pharmaceutical (COLL) stock is held by retail investors.
Who owns the most shares of Collegium Pharmaceutical (COLL)?
iShares owns the most shares of Collegium Pharmaceutical (COLL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.